Related Experiment Video
Updated: Nov 16, 2025

08:07
Procurement of Parathyroid Glands from Living Donor Pigs and Ex Vivo Identification
Published on: August 1, 2025
935
Adipose derived stem cells to construct parathyroid organoid for hypoparathyroidism
Xi Chen1, Jianjun Sun1, Xinping Li1
1Department of Thyroid Center, Shanghai Tongji Hospital, Tongji University School of Medicine, No. 389 Xincun Road, Shanghai, PR China.
Medical Hypotheses
|February 22, 2021
Summary
Researchers are exploring organoid transplantation as a novel treatment for hypoparathyroidism. Adipose-derived stem cells can be differentiated into parathyroid-like cells, forming organoids for potential therapeutic use.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Endocrinology
Background:
- Hypoparathyroidism is a frequent complication following thyroid surgery.
- Organoid transplantation represents a cutting-edge approach for treating endocrine disorders.
- Organoids mimic native organ structures and functions, offering potential for tissue replacement therapy.
Purpose of the Study:
- To investigate the potential of adipose-derived stem cells (ASCs) in generating functional parathyroid organoids.
- To explore biomaterial-assisted assembly of differentiated ASCs for parathyroid tissue engineering.
- To evaluate the feasibility of organoid transplantation as a treatment for hypoparathyroidism.
Main Methods:
- Utilizing a "bottom-up" strategy for in vitro organoid formation.
- Employing intelligent porous hydrogels for scaffold-based tissue engineering.
- Differentiating ASCs into parathyroid-like cells with hormone secretion capabilities.
Main Results:
- ASCs demonstrated differentiation into parathyroid-like cells in vitro.
- Cartilaginous organoids were successfully prepared using hydrogel scaffolds.
- The study provides a foundation for developing biomaterial-assisted parathyroid organoids.
Conclusions:
- Parathyroid organoids can potentially be generated through the assembly of differentiated ASCs.
- This approach holds promise as a future therapeutic strategy for managing hypoparathyroidism.
- Further research is warranted to validate the efficacy and safety of parathyroid organoid transplantation.

